Synopsis

Scholar argues that anti-discrimination law alone cannot address bias hidden in algorithms.

Scholar argues that HHS and the DEA should balance each other’s federal drug scheduling authority.

Scholars argue that the U.S. government should adapt to address rampant loss of regulatory body quorums.

Scholars assess the TVA as a blueprint for publicly owned utilities in the green energy transition.

Scholar urges policymakers to reduce the role of clinicians in overseeing AI use in health care.

Scholar urges courts to play a bigger role in overseeing civil detention facilities.

Scholars argue that regulators have failed to protect child health under pesticide control law.

Scholar argues that to make progress on affordable housing, policymakers must clarify their objectives.

Scholar explores the U.S. Customs and Border Protection’s vital yet overlooked role in IP enforcement.

Scholars argue that energy disclosures increase efficiency and competition without slowing AI development.

Scholars argue that Congress should act to halt expanded presidential trade power.

Scholar argues that Delaware partnerships risk turning investor safeguards into a box-checking exercise.